Novavax and the recombinant protein vaccine: What you need to know

The recombinant protein vaccine develops the body’s immunity against the coronavirus by using the virus' spike proteins. Used by Novavax in developing Covovax, these vaccines often require the incorporation of adjuvants to generate a stronger response against the virus.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gZXjvO
via IFTTT